UBS Group
AGIO icon

UBS Group’s Agios Pharmaceuticals AGIO Stock Holding History

UBS Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,500
Closed -$542K – 8938
2020
Q4 		$542K Hold
12,500
– – ﹤0.01% 4540
2020
Q3 		$438K Buy
+12,500
New +$548K ﹤0.01% 4296
2020
Q2 		– Sell
-9,300
Closed -$330K – 7898
2020
Q1 		$330K Buy
+9,300
New +$430K ﹤0.01% 4319
2015
Q1 		– Sell
-1,400
Closed -$157K – 8735
2014
Q4 		$157K Buy
+1,400
New +$125K ﹤0.01% 5267

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

UBS Group's AGIO Position: Q2 2026 in Review

UBS Group increased its Agios Pharmaceuticals (AGIO) stake by 644% in Q2 2026, buying an estimated $25.9M and bringing the position to 985,831 shares worth $36.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

UBS Group first reported a position in AGIO in Q4 2014 and has held it in 47 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • UBS Group held 985,831 shares of Agios Pharmaceuticals worth $36.6M as of Q2 2026.
  • UBS Group bought 853,291 Agios Pharmaceuticals shares in Q2 2026, an estimated $25.9M.
  • Agios Pharmaceuticals made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2065 holding.
  • UBS Group first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.